UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038239
Receipt number R000043593
Scientific Title Efficacy of conversion surgery for locally advanced biliary tract cancer: a multicenter collaborative study
Date of disclosure of the study information 2019/10/09
Last modified on 2020/10/19 10:02:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of conversion surgery for locally advanced biliary tract cancer: a multicenter collaborative study

Acronym

Efficacy of conversion surgery for locally advanced biliary tract cancer: a multicenter collaborative study

Scientific Title

Efficacy of conversion surgery for locally advanced biliary tract cancer: a multicenter collaborative study

Scientific Title:Acronym

Efficacy of conversion surgery for locally advanced biliary tract cancer: a multicenter collaborative study

Region

Japan Asia(except Japan)


Condition

Condition

biliary tract cancer

Classification by specialty

Hepato-biliary-pancreatic surgery Child

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To establish new evidence by evaluating efficacy and safety of conversion surgery for initially unresectable locally advanced biliary tract cancer.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Overall survival

Key secondary outcomes

Recurrence rate, sites of recurrent disease, R0 resection rate, postoperative complications, effects of tumor shrinkage and adverse events induced by preoperative chemo(radio)therapy


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

Participants must satisfy all of the following items.
Patients with initially unresectable locally advanced biliary tract cancer including intrahepatic cholangiocarcinoma, hilar cholangiocarcinoma, distal bile duct cancer, and gallbladder cancer (diagnosis of resectablility is based on the standard of each participating institution).
Patients who were pathologically diagnosed with biliary tract cancer.
Patients who underwent conversion surgery between January 2013 to December 2017 following chemotherapy or radiotherapy.

Key exclusion criteria

Patients with synchronous multiple cancers.
Patients without completed information on CRFs.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Itaru
Middle name
Last name Endo

Organization

Yokohama City University

Division name

Department of Gastroenterological Surgery

Zip code

2360004

Address

3-9 Fukuura Kanazawaku Yokohama

TEL

0457872650

Email

endoit@yokohama-cu.ac.jp


Public contact

Name of contact person

1st name Yasuhiro
Middle name
Last name Yabushita

Organization

Yokohama City University

Division name

Department of Gastroenterological Surgery

Zip code

2360004

Address

3-9 Fukuura Kanazawaku Yokohama

TEL

0457872650

Homepage URL


Email

yabu23@yokohama-cu.ac.jp


Sponsor or person

Institute

Japanese Society of Hepato-Biliary-Pancreatic Surgery

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Korean Association of Hepato-Biliary-Pancreatic Surgery

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yokohama City University Ethics Committee

Address

3-9 Fukuura Kanazawaku Yokohama

Tel

0457872800

Email

rinri@yokohama-cu.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

JSHBPS-2019-04

Org. issuing International ID_1

Japanese Society of Hepato-Biliary-Pancreatic Surgery

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 10 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2019 Year 04 Month 16 Day

Date of IRB

2019 Year 04 Month 16 Day

Anticipated trial start date

2019 Year 10 Month 08 Day

Last follow-up date

2020 Year 10 Month 31 Day

Date of closure to data entry

2020 Year 10 Month 31 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2019 Year 10 Month 08 Day

Last modified on

2020 Year 10 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043593


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name